Modern and promising therapies for postherpetic neuralgia

Dobrosmyslova A.O.; Khinovker V.V.; Koriachkin V.A.; Pokhabov D.V.

doi:https://doi.org/10.17116/jnevro202512504127

Dobrosmyslova A.O.

Federal Siberian Research Clinical Center

ORCID: 0000-0003-2523-9758

Khinovker V.V.

Federal Siberian Research Clinical Center;
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

ORCID: 0000-0002-3162-6298

Koriachkin V.A.

St. Petersburg State Paediatric Medical University;
Turner National Medical Research Center for Paediatric Traumatology and Orthopedics

ORCID: 0000-0002-3400-8989

Pokhabov D.V.

Federal Siberian Scientific and Clinical Center

ORCID: 0000-0001-5895-5043

Modern and promising therapies for postherpetic neuralgia

Authors:

Dobrosmyslova A.O., Khinovker V.V., Koriachkin V.A., Pokhabov D.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(4): 27‑34

DOI: 10.17116/jnevro202512504127

Read: 1162 times

Contact the author

Table of contents

To cite this article:

Dobrosmyslova AO, Khinovker VV, Koriachkin VA, Pokhabov DV. Modern and promising therapies for postherpetic neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(4):27‑34. (In Russ.)
https://doi.org/10.17116/jnevro202512504127

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Recommended articles:

Potential of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87

Cocarnit in complex therapy of diabetic peripheral polyneuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):73-81

Purinergic mechanisms of pain relief: fashionable topic or real opportunity to improve the quality of analgesic therapy?. Russian Journal of Pain. 2024;(4):86-95

Psychoemotional health of patients with neuropathic pelvic pain under combined magnetic therapy. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2025;(1):12-18

Pharmacological correction of burning eye syndrome. Russian Annals of Ophthalmology. 2025;(2):51-58

Neuropathic pain in chronic inflammatory demyelinating polyneuropathies: analysis of 64 cases. Russian Journal of Pain. 2025;(2):45-53

Abstract:

Postherpetic neuralgia (PHN) is highly prevalent among the elderly and immunocompromised patients and decreases patients’ quality of life. Currently, much attention is paid to the prevention of this disease and the development of new therapies and treatment approaches. The article discusses new targets for treating this type of pain, both pharmacotherapy and invasive methods. Analysis of clinical trials shows that a combination of different therapies can improve symptom management and patients’ quality of life. It was shown that the earlier the treatment of PHN begins, the higher the probability of gaining control over the pain severity. The article emphasizes the need for further research to optimize approaches to PHN treatment and raise the medical community’s awareness about new treatment options.

Keywords:

shingles

herpes

postherpetic neuralgia

neuropathic pain

treatment of neuropathic neuralgia

Authors:

Dobrosmyslova A.O.

Federal Siberian Research Clinical Center

ORCID: 0000-0003-2523-9758

Khinovker V.V.

Federal Siberian Research Clinical Center;
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

ORCID: 0000-0002-3162-6298

Koriachkin V.A.

St. Petersburg State Paediatric Medical University;
Turner National Medical Research Center for Paediatric Traumatology and Orthopedics

ORCID: 0000-0002-3400-8989

Pokhabov D.V.

Federal Siberian Scientific and Clinical Center

ORCID: 0000-0001-5895-5043

Received:

26.11.2024

Accepted:

27.12.2024

Close metadata

References:

Forstenpointner J, Rice ASC, Finnerup NB, et al. Up-date on Clinical Management of Postherpetic Neuralgia and Mechanism-Based Treatment: New Options in Therapy. Journal of infectious diseases. 2018;218(suppl_2):S120-S126. https://doi.org/10.1093/infdis/jiy381
Koriachkin VA, Spasova AP, Khinovker VV. Neuropathic pain. Innovative Medicine of Kuban. 2021;(2):58-64. (In Russ.). https://doi.org/10.35401/2500-0268-2021-22-2-58-64
Klinicheskie rekomendatsii» «Opoyasyvayushchii gerpes» MKB-10: V02 data peresmotra 2020. (In Russ.).
Anosike UG, Ouko I, Mwaura AW, et al. Phenotypes and Genotypes in Postherpetic Neuralgia Drug Therapy: A Narrative Mini-review. The Clinical journal of pain. 2022;38(8):536-540. https://doi.org/10.1097/AJP.0000000000001045
Dermatologiya Fitspatrika v klinicheskoi praktike. T3 Klaus Vol’f, Louell A Goldsmit, Stiven I Kats i dr.; per. s angl.; obshch. Red. Akad. AA Kubanovoi. M.: Izdatel’stvo Panfilova; BINOM. 2013: il. (In Russ.).
Dermatologiya. Illyustrirovannoe rukovodstvo klinicheskoi diagnostiki po professoru Rodionovu AN. Pod red. Rodionova AN. M.: «Granitsa», 2018;944: il. (In Russ.).
Lee C, Jiang N, Tang H, et al. Potential public health impact of the adjuvanted recombinant zoster vaccine among people aged 50 years and older in Beijing. Human vaccines & immunotherapeutics. 2021;17(10):3735-3746. https://doi.org/10.1080/21645515.2021.1932216
Sun Y, Kim E, Kong CL, et al. Effectiveness of the Recombinant Zoster Vaccine in Adults Aged 50 and Older in the United States: A Claims-Based Cohort Study. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2021;73(6):949-956. https://doi.org/10.1093/cid/ciab121
Izurieta HS, Wu X, Forshee R, et al. Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2021;73(6):941-948. https://doi.org/10.1093/cid/ciab125
Chen N, Li Q, Zhang Y, et al. Vaccination for preventing postherpetic neuralgia. The Cochrane database of systematic reviews. 2011;(3):CD007795. https://doi.org/10.1002/14651858.CD007795.pub2
Davydov OS, Yakhno NN, Kukushkin ML, et al. Nevropaticheskaya bol’: klinicheskie rekomendatsii po diagnostike i lecheniyu Rossiiskogo obshchestva po izucheniyu boli. Russian Journal of Pain. 2018;4(58):5-41. (In Russ.). https://doi.org/10.25731/RASP.2018.04.025
Gross GE, Eisert, L, Doerr HW, et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia. Journal der Deutschen Dermatologischen Gesellschaft=Journal of the German Society of Dermatology: JDDG. 2020;18(1):55-78. https://doi.org/10.1111/ddg.14013
Guidelines for the Pharmacological Management of Non-Malignant, Non- Palliative Pain in Primary Care / Non-Specialist Centres. Available online: https://nhsdorset.nhs.uk/Downloads/aboutus/medicines-management/Other%20Guidelines/Pain%20Management%20guidance%202019.pdf
Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European journal of neurology. 2010;17(9):1113-e88. https://doi.org/10.1111/j.1468-1331.2010.02999.x
Ankit S, Zeng TX, Chen YX, et al. The Current Treatment and Prevention of Post Herpetic Neuralgia. Yangtze Medicine. 2018;2:28-38. https://doi.org/10.4236/ym.2018.21003
Mallick-Searle T, Snodgrass B, Brant JM. Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. Journal of multidisciplinary healthcare. 2016;9:447-454. https://doi.org/10.2147/JMDH.S106340
Zhang D, Lei T, Qin L, et al. Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical Trial. JAMA dermatology. 2024;160(11):1182-1191. https://doi.org/10.1001/jamadermatol.2024.3410
Huang Y, Xu C, Zeng T, et al. Intravenous patient-controlled analgesia hydromorphone combined with pregabalin for the treatment of postherpetic neuralgia: a multicenter, randomized controlled study. The Korean journal of pain. 2021;34(2):210-216. https://doi.org/10.3344/kjp.2021.34.2.210
Rice ASC, Dworkin RH, Finnerup NB, et al. Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy. Pain. 2021;162(10):2578-2589. https://doi.org/10.1097/j.pain.0000000000002252
Efficacy and Safety of TRK-700 in Patient with Post-Herpetic Neuralgia—Full Text View—ClinicalTrials.Gov. [(accessed on 24 June 2023)]; Available online: https://classic.clinicaltrials.gov/ct2/show/NCT02701374
Efficacy and Safety of LX9211 in Patients with Postherpetic Neuralgia—Full Text View—ClinicalTrials.Gov. [(accessed on 24 June 2023)]; Available online: https://classic.clinicaltrials.gov/ct2/show/NCT04662281
Oral LAT8881 in Neuropathic Pain—Full Text View—ClinicalTrials.Gov. [(accessed on 25 June 2023)]; Available online: https://classic.clinicaltrials.gov/ct2/show/NCT03865953
To Evaluate the Efficacy and Safety of SR419 in Patients with Postherpetic Neuralgia (PHN)—Full Text View—ClinicalTrials.Gov. [(accessed on 25 June 2023)]; Available online: https://classic.clinicaltrials.gov/ct2/show/NCT05357677
The Study on the Esketamine in the Treatment of Postherpetic Neuralgia—Full Text View—ClinicalTrials.Gov. [(accessed on 25 June 2023)]; Available online: https://classic.clinicaltrials.gov/ct2/show/NCT04664530
Wang H, Romano G, Fedgchin M, et al. Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Placebo-controlled, Phase-2 Study. The Clinical journal of pain. 2017;33(2):99-108. https://doi.org/10.1097/AJP.0000000000000388
Hou Q, Barr T, Gee L, et al. Keratinocyte expression of calcitonin gene-related peptide β: implications for neuropathic and inflammatory pain mechanisms. Pain. 2011;152(9):2036-2051. https://doi.org/10.1016/j.pain.2011.04.033
Zhu J, Luo G, He Q, et al. Evaluation of the efficacy of unipolar and bipolar spinal dorsal root ganglion radiofrequency thermocoagulation in the treatment of postherpetic neuralgia. The Korean Journal of Pain. 2022;35(1):114-123. https://doi.org/10.3344/kjp.2022.35.1.114
Yang F, Liao P, You Y, et al. The effectiveness of repetitive paravertebral block with ropivacaine and dexmedetomidine for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Postepy dermatologii i alergologii. 2022;39(1):116-120. https://doi.org/10.5114/ada.2021.106021
Lu F, Zhong J, Liu H, et al. CT-guided paravertebral injection of doxorubicin for treatment of postherpetic neuralgia: a database-based retrospective stratified study. Frontiers in neurology. 2023;14:1258464. https://doi.org/10.3389/fneur.2023.1258464
Xiao L, Mackey S, Hui H, et al. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. Pain medicine (Malden, Mass.). 2010;11(12):1827-1833. https://doi.org/10.1111/j.1526-4637.2010.01003.x
Chen L, Zhang Y, Chen Y, et al. Efficacy and Safety of Botulinum Toxin A and Pulsed Radiofrequency on Postherpetic Neuralgia: A Randomized Clinical Trial. Contrast media & molecular imaging. 2022;1579937. https://doi.org/10.1155/2022/1579937
Atlas intervetsionnogo lecheniya boli. Pod red. Voloshina A.G., Genova P.G. M.: «AILB». 2023;528. ISBN 978-5-6050092-0-7. (In Russ.).
Isagulyan ED, Konovalov NA. Neiromodulyatsiya boli. Effektivnoe kontrolirovanie tyazhelykh bolevykh sindromov. M.: Izdatel’stvo «IP TA Alekseeva». 2020;840, ill. ISBN 978-5-905221-23-1. (In Russ.).
Wang M, Zhang J, Zheng L, et al. Ultrasound-Guided Continuous Thoracic Paravertebral Infusion of Methylene Blue in the Treatment of Postherpetic Neuralgia: A Prospective, Randomized, Controlled Study. Pain and therapy. 2021;10(1):675-689. https://doi.org/10.1007/s40122-021-00265-w
Honda Pazili T. Treatment of postherpetic neuralgia by bone marrow aspirate injection: A case report. World journal of clinical cases. 2023;11(15):3619-3624. https://doi.org/10.12998/wjcc.v11.i15.3619